Using Skin Biopsies to Diagnose Parkinson's Disease and Related Disorders
Author Information
Author(s): Isaacson Jonathan R., Freeman Roy, Gibbons Christopher H.
Primary Institution: Center of Autonomic and Peripheral Nerve Disorders, Beth Israel Deaconess Medical Center, Boston, MA, United States
Hypothesis
Can skin biopsy detection of phosphorylated alpha-synuclein improve the diagnosis and management of synucleinopathies?
Conclusion
Skin biopsy detection of phosphorylated alpha-synuclein significantly improves the diagnosis and treatment of patients suspected to have synucleinopathies.
Supporting Evidence
- 78% of patients had a change in their clinical care after skin biopsy results.
- 66% of patients experienced a change in their diagnosis.
- 55% of patients had a change in their treatment based on biopsy results.
Takeaway
Doctors can take a small piece of skin to check for a specific protein that helps them figure out if someone has certain brain diseases like Parkinson's.
Methodology
A retrospective chart review of patients who underwent skin biopsy for detection of phosphorylated alpha-synuclein was conducted to assess changes in diagnosis and treatment.
Potential Biases
The retrospective nature of the study may introduce bias in interpreting clinical results.
Limitations
The study is limited by its retrospective design, small sample size, and potential outcome bias from chart reviews.
Participant Demographics
Mean age of participants was 71 years, with a range from 52 to 89 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website